News Biogen pays Remedy $120m to bolster stroke pipeline Acquisition provides Biogen a fall back molecule in this high risk therapy area.
News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Apitope aims to bounce back from MS setback Biotech looks for funding and long-term development partner
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
